Dan Rubin

Dan Rubin is President and CEO of PARx Solutions.


5 PA Predictions for the Coming Year

Death by Prior Authorization

Health plans should pause in calling for prescription prior authorizations or answer the call for process reform to ensure effective patient care.

Generating High PA Approval Rates: Important But Not Sufficient

Brands that wish to overcome prior authorization (PA) challenges should work with service providers that generate high approvals on submitted PAs and drive more submissions from prescribers, writes Dan Rubin.

Tackling the Prior Authorization Challenge: A Critical Task for Pharma

Effectively addressing prior authorization challenges as part of a company’s core sales and marketing tactics can yield tangible and substantial benefits, writes Dan Rubin.